Relationship of Treatment-Related Cytopenias and Response to Lenalidomide in Patients With Lower-Risk Myelodysplastic Syndromes

2008107 citationsJournal Article

Authors

Mikkael A. Sekeres · Cleveland Clinic

Jaroslaw P. Maciejewski · University of South Florida

Aristoteles Giagounidis · University of South Florida

Kenton Wride · St. Vincent's Medical Center

Robert Knight · St. Vincent's Medical Center

Azra Raza · St. Vincent's Medical Center

Alan F. List

Abstract

These findings support the hypothesis that a direct cytotoxic effect of lenalidomide specific to the del(5q) clone may be indicative of a TI response.

Topics & Keywords

Acute Myeloid Leukemia Research Hematopoietic Stem Cell Transplantation Multiple Myeloma Research and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 26, Issue 36, pp. 5943-5949

DOI: 10.1200/jco.2007.15.5770

Field-Weighted Citation Impact: 6.25

Command Palette